Clinical Trials Browser

Completed × INDUSTRY × icotinib × Clear all

NCT02044328 2022-02-08

ICAPE

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung

NCT01855854 2019-07-05

Second-line Treatment With Icotinib in Esophageal Carcinoma Patients With EGFR Overexpression (IHC 3+) or Positive FISH

Phase 2 Completed

Gastrointestinal

Esophageal Neoplasms

NCT02486354 2015-07-01

Icotinib in Advanced Metastatic Patients With NSCLC Previously Treated With Chemotherapy

Phase 3 Completed

Carcinoma, Non-Small-Cell Lung

NCT01465243 2014-02-17

Dose Escalation Of Icotinib In Previously Treated Patients With Routine Dose

Phase 4 Completed

Carcinoma, Non-Small-Cell Lung

NCT01516983 2014-02-17

Icotinib Combined With WBRT For NSCLC Patients With Brain Metastases and EGFR Mutation

Phase 1/2 Completed

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT01040780 2014-02-14

ICOGEN

Phase 3 Completed

399 enrolled 12 charts

Carcinoma, Non-Small-Cell Lung